Patents by Inventor David Greenberg

David Greenberg has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 11142764
    Abstract: Provided are antisense oligomers targeted against bacterial mRNAs and other macromolecules associated with a biochemical pathway and/or cellular process, and related compositions and methods of using the oligomers and compositions to treat an infected mammalian subject, for example, as primary antimicrobials or as adjunctive therapies with classic antimicrobials.
    Type: Grant
    Filed: December 22, 2016
    Date of Patent: October 12, 2021
    Assignees: Board of Regents, The University of Texas System, Oregon State University
    Inventors: David Greenberg, Bruce L. Geller
  • Publication number: 20210266684
    Abstract: An auditory device assembly (1) comprises an earpiece (3) having an audio output device (7) for an ear (9) of a user and an audio processing unit (11, 33). The audio processing unit (11, 33) has a hearing-test mode and an audio streaming mode. In the hearing test mode the audio processing unit (11, 33) is arranged to determine at least one ear characteristic of the ear of the user based on at least one hearing test. In the audio streaming mode the audio processing unit (11, 33) is arranged to output an audio stream via the audio output device (7). The audio processing unit (11, 33) is arranged to adjust the output of the audio stream in the audio streaming mode based on the at least one ear characteristic determined in the hearing-test mode.
    Type: Application
    Filed: May 7, 2021
    Publication date: August 26, 2021
    Inventors: David GREENBERG, Clive TAYLOR
  • Publication number: 20210205565
    Abstract: In some embodiments, the present invention provides a method for treating bronchiolitis in an infant in need thereof, wherein the wherein the method comprises repeatedly administering to the infant a gas mixture comprising nitric oxide at a concentration from about 144 to about 176 ppm for a first period of time, followed by a gas mixture containing no nitric oxide for a second period of time, wherein the administration is repeated for a time sufficient to: a) reduce the length of time of hospitalization required to achieve oxygen saturation greater than or equal to 92% in room air, compared an infant that is not subjected to the repeated administration of nitric oxide; b) reduce the length of time of hospitalization required to achieve a clinical score of less than or equal to 5, compared an infant that is not subjected to the repeated administration of nitric oxide; c) reduce the length of time of hospitalization required to be discharged, compared an infant that is not subjected to the repeated adminis
    Type: Application
    Filed: January 27, 2021
    Publication date: July 8, 2021
    Inventors: Yossef Av-Gay, David Greenberg, Asher Tal
  • Patent number: 11029895
    Abstract: Systems and methods for placing visual content on a virtual surface for customizing a physical product are disclosed. According to certain aspects, an electronic device may, in conjunction with enabling a user to customize a product design, access and identify certain parameters associated with certain page boxes of the electronic document. The electronic device may calculate a set of differences between certain aspect ratios associated with the page boxes, and accordingly modify certain parameters of the page boxes. The resulting page box modifications may mitigate certain errors associated with production of the product.
    Type: Grant
    Filed: November 12, 2019
    Date of Patent: June 8, 2021
    Assignee: CIMPRESS SCHWEIZ GMBH
    Inventors: Harrison Paine, David Greenberg, Anatoliy Tsykora, Vikramaditya Khemka
  • Patent number: 11021706
    Abstract: Provided are antisense morpholino oligomers targeted against bacterial virulence factors such as genes that contribute to antibiotic resistance or biofilm formation, or genes associated with fatty acid biosynthesis, and related compositions and methods of using the oligomers and compositions, for instance, in the treatment of an infected mammalian subject.
    Type: Grant
    Filed: September 1, 2017
    Date of Patent: June 1, 2021
    Assignees: Board of Regents, The University of Texas System, Oregon State University
    Inventors: Bruce L. Geller, David Greenberg
  • Publication number: 20210155934
    Abstract: Provided are antisense morpholino oligomers targeted against bacterial virulence factors such as genes that contribute to antibiotic resistance or biofilm formation, or essential genes, and related compositions and methods of using the oligomers and compositions, for instance, in the treatment of an infected mammalian subject.
    Type: Application
    Filed: February 1, 2021
    Publication date: May 27, 2021
    Applicants: Board of Regents, The University of Texas System, Oregon State University
    Inventors: David GREENBERG, Bruce L. GELLER, Erdal TOPRAK
  • Publication number: 20210141576
    Abstract: Systems and methods for placing visual content on a virtual surface for customizing a physical product are disclosed. According to certain aspects, an electronic device may, in conjunction with enabling a user to customize a product design, access and identify certain parameters associated with certain page boxes of the electronic document. The electronic device may calculate a set of differences between certain aspect ratios associated with the page boxes, and accordingly modify certain parameters of the page boxes. The resulting page box modifications may mitigate certain errors associated with production of the product.
    Type: Application
    Filed: November 12, 2019
    Publication date: May 13, 2021
    Inventors: Harrison Paine, David Greenberg, Anatoliy Tsykora, Vikramaditya Khemka
  • Patent number: 11006225
    Abstract: An auditory device assembly (1) comprises an earpiece (3) having an audio output device (7) for an ear (9) of a user and an audio processing unit (11, 33). The audio processing unit (11, 33) has a hearing-test mode and an audio streaming mode. In the hearing test mode the audio processing unit (11, 33) is arranged to determine at least one ear characteristic of the ear of the user based on at least one hearing test. In the audio streaming mode the audio processing unit (11, 33) is arranged to output an audio stream via the audio output device (7). The audio processing unit (11, 33) is arranged to adjust the output of the audio stream in the audio streaming mode based on the at least one ear characteristic determined in the hearing-test mode.
    Type: Grant
    Filed: November 10, 2017
    Date of Patent: May 11, 2021
    Assignee: EARTEX LIMITED
    Inventors: David Greenberg, Clive Taylor
  • Patent number: 10907158
    Abstract: Provided are antisense morpholino oligomers targeted against bacterial virulence factors such as genes that contribute to antibiotic resistance or biofilm formation, or essential genes, and related compositions and methods of using the oligomers and compositions, for instance, in the treatment of an infected mammalian subject.
    Type: Grant
    Filed: December 22, 2016
    Date of Patent: February 2, 2021
    Assignees: Board of Regents, The University of Texas System, Oregon State University
    Inventors: David Greenberg, Bruce L. Geller, Erdal Toprak
  • Publication number: 20200283768
    Abstract: Provided are antisense oligomers targeted against bacterial mRNAs and other macromolecules associated with a biochemical pathway and/or cellular process, and related compositions and methods of using the oligomers and compositions to treat an infected mammalian subject, for example, as primary antimicrobials or as adjunctive therapies with classic antimicrobials.
    Type: Application
    Filed: October 19, 2018
    Publication date: September 10, 2020
    Applicants: Board of Regents, The University of Texas System, Oregon State University
    Inventors: Bruce L. GELLER, David GREENBERG
  • Publication number: 20200276229
    Abstract: A method of treating a human subject which is effected by intermittent inhalation of gaseous nitric oxide at a concentration of at least 160 ppm is disclosed. The method can be utilized for treating a human subject suffering from, or prone to suffer from, a disease or disorder that is manifested in the respiratory tract, or from a disease or disorder that can be treated via the respiratory tract. The disclosed method can be effected while monitoring one or more of on-site and off-site parameters such as vital signs, methemoglobin levels, pulmonary function parameters, blood chemistry and hematological parameters, blood coagulation parameters, inflammatory marker levels, liver and kidney function parameters and vascular endothelial activation parameters, such that no substantial deviation from a baseline in seen in one or more of the monitored parameters.
    Type: Application
    Filed: May 20, 2020
    Publication date: September 3, 2020
    Inventors: Yossef Av-Gay, Christopher C. Miller, David Greenberg
  • Publication number: 20200246573
    Abstract: In some embodiments, the present invention provides a method for treating bronchiolitis in an infant in need thereof, wherein the wherein the method comprises repeatedly administering to the infant a gas mixture comprising nitric oxide at a concentration from about 144 to about 176 ppm for a first period of time, followed by a gas mixture containing no nitric oxide for a second period of time, wherein the administration is repeated for a time sufficient to: a) reduce the length of time of hospitalization required to achieve oxygen saturation greater than or equal to 92% in room air, compared an infant that is not subjected to the repeated administration of nitric oxide; b) reduce the length of time of hospitalization required to achieve a clinical score of less than or equal to 5, compared an infant that is not subjected to the repeated administration of nitric oxide; c) reduce the length of time of hospitalization required to be discharged, compared an infant that is not subjected to the repeated adminis
    Type: Application
    Filed: February 11, 2020
    Publication date: August 6, 2020
    Inventors: Yossef Av-Gay, David Greenberg, Asher Tal
  • Publication number: 20200215102
    Abstract: A method of treating a human subject which is effected by intermittent inhalation of gaseous nitric oxide at a concentration of at least 160 ppm is disclosed. The method can be utilized for treating a human subject suffering from, or prone to suffer from, a disease or disorder that is manifested in the respiratory tract, or from a disease or disorder that can be treated via the respiratory tract. The disclosed method can be effected while monitoring one or more of on-site and off-site parameters such as vital signs, methemoglobin levels, pulmonary function parameters, blood chemistry and hematological parameters, blood coagulation parameters, inflammatory marker levels, liver and kidney function parameters and vascular endothelial activation parameters, such that no substantial deviation from a baseline in seen in one or more of the monitored parameters.
    Type: Application
    Filed: March 2, 2020
    Publication date: July 9, 2020
    Inventors: Yossef Av-Gay, Christopher C. Miller, David Greenberg
  • Publication number: 20200102559
    Abstract: Method for controlling for the appearance of seizures in the mammalian brain comprising modifying the abundance of a specific miRNA-miR-211, for uses in preventing seizures and providing a model system to examine the effect of a drug or a treatment to seizures.
    Type: Application
    Filed: March 26, 2019
    Publication date: April 2, 2020
    Inventors: Uriah Bekenstein, Hermona SOREQ, David Greenberg
  • Publication number: 20200032254
    Abstract: Provided are antisense morpholino oligomers targeted against bacterial virulence factors such as genes that contribute to antibiotic resistance or biofilm formation, or genes associated with fatty acid biosynthesis, and related compositions and methods of using the oligomers and compositions, for instance, in the treatment of an infected mammalian subject.
    Type: Application
    Filed: September 1, 2017
    Publication date: January 30, 2020
    Inventors: Bruce L. Geller, David Greenberg
  • Publication number: 20190298575
    Abstract: A nitric oxide gas-releasing conduit configured for surgical implantation through a patient's tympanic membrane. The nitric oxide gas-releasing conduit comprises a gas-permeable cured resin material configured for releasably sequestering therein gas. The gas-permeable cured resin material is charged with nitric oxide gas. The nitric oxide gas-releasing conduit may be optionally coated with an antimicrobial gas-releasing composition. The gas-releasing coating composition may be configured to release nitric oxide.
    Type: Application
    Filed: June 18, 2019
    Publication date: October 3, 2019
    Inventors: Yossef AV-GAY, David GREENBERG
  • Publication number: 20190289409
    Abstract: An auditory device assembly (1) comprises an earpiece (3) having an audio output device (7) for an ear (9) of a user and an audio processing unit (11, 33). The audio processing unit (11, 33) has a hearing-test mode and an audio streaming mode. In the hearing test mode the audio processing unit (11, 33) is arranged to determine at least one ear characteristic of the ear of the user based on at least one hearing test. In the audio streaming mode the audio processing unit (11, 33) is arranged to output an audio stream via the audio output device (7). The audio processing unit (11, 33) is arranged to adjust the output of the audio stream in the audio streaming mode based on the at least one ear characteristic determined in the hearing-test mode.
    Type: Application
    Filed: November 10, 2017
    Publication date: September 19, 2019
    Inventors: David GREENBERG, Clive TAYLOR
  • Patent number: 10391098
    Abstract: Provided are antisense oligomers targeted against or genes associated with a biochemical pathway and/or cellular process, and related compositions and methods of using the oligomers and compositions to treat an infected mammalian subject, for example, as primary antimicrobials or as adjunctive therapies with classic antimicrobials.
    Type: Grant
    Filed: May 15, 2015
    Date of Patent: August 27, 2019
    Assignees: Board of Regents, The University of Texas System, Oregon State University
    Inventors: Bruce L. Geller, David Greenberg
  • Patent number: 10350112
    Abstract: A nitric oxide gas-releasing conduit configured for surgical implantation through a patient's tympanic membrane. The nitric oxide gas-releasing conduit comprises a gas-permeable cured resin material configured for releasably sequestering therein gas. The gas-permeable cured resin material is charged with nitric oxide gas. The nitric oxide gas-releasing conduit may be optionally coated with an antimicrobial gas-releasing composition. The gas-releasing coating composition may be configured to release nitric oxide.
    Type: Grant
    Filed: June 29, 2010
    Date of Patent: July 16, 2019
    Assignee: ENOX (ISRAEL) LTD.
    Inventors: Yossef Av-Gay, David Greenberg
  • Publication number: 20190169609
    Abstract: Provided are antisense oligonucleotides targeted against bacterial genes involved in biochemical pathways and/or cellular processes, and related compositions and methods of using the oligonucleotides and compositions, alone or in combination with other antimicrobial agents, for instance, in the treatment of an infected mammalian subject.
    Type: Application
    Filed: December 23, 2015
    Publication date: June 6, 2019
    Inventors: Bruce L. Geller, David Greenberg